Cor Vasa 2024, 66(3):307-311 | DOI: 10.33678/cor.2024.002

Predictors of major adverse cardiovascular events in patients with coronary artery perforation treated with covered stents

Umeyir Savur, Aysel Akhundova, Başak Çatalbaş, İbrahim Oguz Karaca
Department of Cardiology, Medipol Mega University Hospital, Faculty of Medicine, Istanbul, Turkey

Background: Coronary artery perforation (CAP) is a rare, life-threatening complication of percutaneous coronary intervention (PCI). PTFE-coated stents are highly successful and lifesaving in the treatment of coronary perforation. The incidence of thrombosis and restenosis in the PTFE-covered stent is higher than in standard stents. The aim of this study was to evaluate the clinical outcomes of PTFE-covered stents for CAP.

Materials and methods: We evaluated a total of 38 patients who were treated with PTFE-coated stents for coronary perforation from January 2012 to January 2022 at a single high-volume center, Medipol University Hospital in Turkey. The primary endpoint was the composite of major adverse cardiovascular events (MACEs).

Results: The one-year outcomes of the patients who had PTFE-coated stents implanted after CAP were investigated. A total of 38 patients, 22 (58%) males and 16 (42%) females, were included. The mean age was 69.7±11.4 years. MACE developed in 37% of the population (14 patients) in the follow-up. The target vessel revascularization (TVR) rate at one year was 36.8% (14 patients), the target lesion revascularization (TLR) rate at one year was 21% (8 patients), the incidence of death was 10.5% (4 patients), of myocardial infarction 21.1% (8 patients).

Conclusions: Today, although the majority of coronary perforation cases are successfully treated with PTFE-coated stents, the one-year outcome of MACE in CS implanted patients is high. These results showed that such patients should be closely monitored.

Keywords: Coronary artery perforation, Covered stent, Percutaneous coronary intervention, Polytetrafluoroethylene (PTFE)-coated stents

Received: November 14, 2023; Revised: December 29, 2023; Accepted: January 3, 2024; Prepublished online: June 2, 2012; Published: June 28, 2024  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Savur U, Akhundova A, Çatalbaş B, Karaca İO. Predictors of major adverse cardiovascular events in patients with coronary artery perforation treated with covered stents. Cor Vasa. 2024;66(3):307-311. doi: 10.33678/cor.2024.002.
Download citation

References

  1. Shimony A, Joseph L, Mottillo S, Eisenberg MJ. Coronary artery perforation during percutaneous coronary intervention: a systematic review and meta-analysis. Can J Cardiol 2011;27:843-850. Go to original source... Go to PubMed...
  2. Harnek J, James S, Lagerqvist B. Coronary artery perforation and tamponade incidence, risk factors, predictors and outcomes from 12 years' data of the SCAAR Registry. Circ J 2019;84:43-53. Go to original source... Go to PubMed...
  3. Ellis SG, Ajluni S, Arnold AZ. Increased coronary perforation in the new device era. Incidence, classification, management, and outcome. Circulation 1994;90:2725-2730. Go to original source... Go to PubMed...
  4. Stankovic G, Orlic D, Corvaja N. Incidence, predictors, in- -hospital, and late outcomes of coronary artery perforations. Am J Cardiol 2004;93:213-216. Go to original source... Go to PubMed...
  5. Shimony A, Zahger D, Van Straten M, et al. Incidence, risk factors, management and outcomes of coronary artery perforation during percutaneous coronary intervention. Am J Cardiol 2009;104:1674-1677. Go to original source... Go to PubMed...
  6. Mohammed Al-M, Prashanth P, Kadhim S. Coronary Perforation and Covered Stents: An Update and Review. Heart Views 2011;12:63-70. Go to original source... Go to PubMed...
  7. Takano M, Yamamoto M, Inami S, et al. Delayed Endothelialization After Polytetrafluoroethylene-Covered Stent Implantation for Coronary Aneurysm. Circ J 2009;73:190-193. Go to original source... Go to PubMed...
  8. von Korn H, Stefan V, van Ewijk R, et al. Treatment of coronary bifurcation lesions: stent-covering of the side branch with and without PCI of the side branch: a retrospective analysis of all consecutive patients. BMC Cardiovascular Disorders 2013;13:27. Go to original source... Go to PubMed...
  9. Nagaraja V, Schwarz K, Moss S, et al. Outcomes of patients who undergo percutaneous coronary intervention with covered stents for coronary perforation: A systematic review and pooled analysis of data. Catheter Cardiovasc Interv 2020;96:1360-1366. Go to original source... Go to PubMed...
  10. Takano M, Yamamoto M, Inami S, et al. Delayed Endothelialization After Polytetrafluoroethylene Covered Stent Implantation for Coronary Aneurysm. Circ J 2009;73:190-193. Go to original source... Go to PubMed...
  11. Ford TJ, Khan A, Docherty KF, et al. Sex differences in procedural and clinical outcomes following rotational atherectomy. Catheter Cardiovasc Interv 2020;95:232-241. Go to original source... Go to PubMed...
  12. Mozos I, Maidana JP, Stoian D, Stehlik M. Gender differences of arterial stiffness and arterial age in smokers. Int J Environ Res Public Health 2017;14:565. Go to original source... Go to PubMed...
  13. Asghari E, Gholizadeh L, Kazami L, et al. Symptom recognition and treatment-seeking behaviors in women experiencing acute coronary syndrome for the first time: a qualitative study. BMC Cardiovasc Disord 2022;22:508. Go to original source... Go to PubMed...
  14. Wańha W, Januszek R, Kołodziejczak M, et al. Procedural and 1-year outcomes following large vessel coronary artery perforation treated by covered stents implantation: Multicentre CRACK registry. PLoS One 2021;16:e0249698. Go to original source... Go to PubMed...
  15. Mikhail P, Howden N, Monjur M, et al. Coronary perforation incidence, outcomes and temporal trends (COPIT): a systematic review and meta-analysis. Open Heart 2022;9:e002076. Go to original source... Go to PubMed...

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.





Cor et Vasa

You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.